Physician profile
Ryan Holland
NPI 1427580455
$3,030.13
in general payments reported to CMS, 2019-2025
10 companies · $1,455 in 2025
The $1,455 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $229 · 2024: $1,346 · 2025: $1,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,591 · Food and Beverage: $1,210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,590.59 |
| Food and Beverage | $1,210.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,378.08 | 2024-2025 | Target, Surpass Evolve, Neuroform Ez 3 |
| Nico Corporation | $229.40 | 2021 | |
| Depuy Synthes Sales INC. | $183.78 | 2025 | Embotrap, Trufill |
| Cerapedics INC. | $89.67 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Chiesi USA, INC. | $47.32 | 2025 | Cleviprex |
| Microtransponder, INC. | $28.11 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.39 | 2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.72 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.47 | 2025 | Aralast |
| Bioventus LLC | $14.19 | 2025 | Bonescalpel & Sonicone (O.R.) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Holland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.